Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 20.09M | $1.71B | -- | +3.55M | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 18.72M | $1.59B | -- | +1.19M | 2026-06-30 |
| Wellington Management Group LLP | 6.93M | $590.0M | -- | -1.08M | 2026-06-30 |
| Vanguard Portfolio Management LLC | 6.71M | $571.0M | -- | +868.0K | 2026-06-30 |
| State Street Corp | 6.49M | $553.0M | -- | +749.0K | 2026-06-30 |
| Vanguard Capital Management LLC | 6.12M | $521.0M | -- | +628.9K | 2026-06-30 |
| FMR LLC | 5.03M | $428.0M | -- | -5.69M | 2026-06-30 |
| Avoro Capital Advisors LLC | 5.00M | $425.0M | -- | +1.67M | 2026-06-30 |
| Bank of America Corp | 4.64M | $394.0M | -- | +1.51M | 2026-06-30 |
| Geode Capital Management, LLC | 3.71M | $316.0M | -- | +497.1K | 2026-06-30 |
